Published Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Member News
Copy The Link to the  Article
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development
Copy The Link to the  Article

Related or similar articles

View more News
March 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

First in vivo validation of KLRG1 as a new cancer immunotherapy target
Member News
January 3, 2025

Exciting Equipment Additions to Labshares: Innovating Your Research

Labshares News
November 2, 2018

Life Sciences Co-Working Incubator Labshares Launches in Newton

A new office and laboratory incubator for emerging biotechnology and life science companies has just opened in Newton’s Charles River Mill District.
Labshares News